Trademarkia Logo

Australia

AU$
AMYLYX
Published: Under examination

Last updated on 9 May 2025

Owner Info

Amylyx Pharmaceuticals, Inc.

43 Thorndike Street

Cambridge MA 02141, UNITED STATES OF AMERICA

Serial Number

2542257 filed on 21 Mar 2025

Correspondent

Fish & Richardson P.C.

PO Box 1022,

Minneapolis MN 55440-1022,

UNITED STATES OF AMERICA

AMYLYX

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of endocrine, metabolic, and hormonal related diseases and disorders.

Mark Details


Serial Number

2542257

Registered On

NA

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

2 Oct 2024

Mark Type

US

Legal History


Show more

Status DateAction Taken
9th May 2025Adverse Report (Examination) correspondence sent
8th May 2025IP Right has been Examined
29th Apr 2025Awaiting examination
29th Apr 2025Examination expedited
24th Apr 2025IP Right Filed Published
24th Apr 2025Status change to Published
24th Apr 2025IP right goods and service classes updated
24th Apr 2025IP Right Goods and Services Items updated
24th Apr 2025Status change to Filed
24th Apr 2025Status change to Received